Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,shortTermInvestments,netReceivables,inventory,accountsPayable,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,changeToInventory,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,currency,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingPE,epsTrailingTwelveMonths,epsForward,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,exchange,exchangeDataDelayedBy,marketState,twoHundredDayAverageChangePercent,shortName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,market,priceHint,regularMarketChangePercent,regularMarketDayRange,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry
t0,ILM1.DE,110528000.0,16085000,,,2925000,,1795000,5901000,10883000,3377000,3377000,772000,-29000,,,,1130000,173978000,170601000,163095000,-452000,,1795000,1795000,13542000.0,52112000.0,142425000.0,4952000.0,194537000.0,16085000.0,548000.0,21853000.0,4837000.0,18355000.0,104487000.0,3661000.0,19788000.0,30628000.0,104487000.0,22384000.0,136305000.0,290000.0,515000.0,80144000.0,35310000.0,22398000.0,-62000,-27989000,-1669000,-298000,-738000,125000,1459000,-47468000,-45062000,833000,14000,-51428000,30857000,-1899000,745000,-783000,105677000.0,en-US,US,EQUITY,False,Delayed Quote,EUR,40.0,39.15,39.3,0,0,finmb_364624951,XETRA,Medios AG,EUR,11330,17319,15.599998,0.65822774,23.7 - 41.4,-2.1000023,-0.050724693,23.7,41.4,1634036340,1634036340,1634036340,103.42105,0.38,0.82,8.855,36.37,2.9300003,0.080560915,35.592255,3.7077446,629432704,47.92683,4.4381704,15,Europe/Berlin,CEST,7200000,False,False,GER,0,REGULAR,0.104172796,MEDIOS AG  O.N.,39.3,1630573220,-0.70000076,40.25,40.25,39.0,9866,de_market,2,-1.7500019,39.0 - 40.25,1.23,,,41.4,23.7,36.37,35.59,11.33k,17.32k,16.09M,,8.34M,24.94%,34.94%,,,,,,,,,,,0.00%,,,1:4,"Jul 19, 2012","Dec 31, 2020","Dec 31, 2020",0.97%,1.70%,4.29%,5.41%,626.89M,40.57,19.50%,37.12M,12.47M,6.06M,0.38,-0.40%,20.3M,1.26,19.23M,13.51,4.45,8.85,-38.12M,-43.68M,Value,10557,Healthcare,187,"Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures drugs for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.",Berlin,49 30 232 5668 0,1577750400,Germany,http://www.medios.ag,86400,Heidestrasse 9,49 30 232 5668 01,Medical Distribution
t-1,ILM1.DE,105580000.0,16085000,,,1803000,,1101000,3784000,8764000,2693000,2693000,1515000,-29000,,,,702000,160015000,157322000,151251000,-890000,,1101000,1101000,34391000.0,68974000.0,139971000.0,7092000.0,208945000.0,16085000.0,6839000.0,20058000.0,5081000.0,,103828000.0,,67256000.0,57315000.0,103828000.0,10936000.0,163398000.0,220000.0,,57239000.0,32064000.0,48987000.0,21000,29489000,-899000,-17856000,-18182000,-6000,1459000,-19054000,28000,772000,1000,-51428000,-26053000,-326000,-5275000,-393000,106083000.0,en-US,US,EQUITY,False,Delayed Quote,EUR,40.0,39.15,39.3,0,0,finmb_364624951,XETRA,Medios AG,EUR,11330,17319,15.599998,0.65822774,23.7 - 41.4,-2.1000023,-0.050724693,23.7,41.4,1634036340,1634036340,1634036340,103.42105,0.38,0.82,8.855,36.37,2.9300003,0.080560915,35.592255,3.7077446,629432704,47.92683,4.4381704,15,Europe/Berlin,CEST,7200000,False,False,GER,0,REGULAR,0.104172796,MEDIOS AG  O.N.,39.3,1630573220,-0.70000076,40.25,40.25,39.0,9866,de_market,2,-1.7500019,39.0 - 40.25,1.23,,,41.4,23.7,36.37,35.59,11.33k,17.32k,16.09M,,8.34M,24.94%,34.94%,,,,,,,,,,,0.00%,,,1:4,"Jul 19, 2012","Dec 31, 2020","Dec 31, 2020",0.97%,1.70%,4.29%,5.41%,626.89M,40.57,19.50%,37.12M,12.47M,6.06M,0.38,-0.40%,20.3M,1.26,19.23M,13.51,4.45,8.85,-38.12M,-43.68M,Value,10557,Healthcare,187,"Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures drugs for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.",Berlin,49 30 232 5668 0,1577750400,Germany,http://www.medios.ag,86400,Heidestrasse 9,49 30 232 5668 01,Medical Distribution
t-2,ILM1.DE,104573000.0,16085000,,,802000,,859000,3688000,8414000,930000,930000,2801000,-230000,,,,-57000,130067000,129137000,121653000,-128000,,859000,859000,34122000.0,63451000.0,138695000.0,11771000.0,202146000.0,16085000.0,3168000.0,18958000.0,5176000.0,,103652000.0,,86310000.0,51341000.0,103652000.0,11231000.0,156552000.0,241000.0,,46727000.0,20347000.0,20720000.0,21000,-6556000,-1142000,19046000,70987000,52000,52010000,87227000,17383000,820000,7000,21661000,-26053000,-69000,547000,-747000,105211000.0,en-US,US,EQUITY,False,Delayed Quote,EUR,40.0,39.15,39.3,0,0,finmb_364624951,XETRA,Medios AG,EUR,11330,17319,15.599998,0.65822774,23.7 - 41.4,-2.1000023,-0.050724693,23.7,41.4,1634036340,1634036340,1634036340,103.42105,0.38,0.82,8.855,36.37,2.9300003,0.080560915,35.592255,3.7077446,629432704,47.92683,4.4381704,15,Europe/Berlin,CEST,7200000,False,False,GER,0,REGULAR,0.104172796,MEDIOS AG  O.N.,39.3,1630573220,-0.70000076,40.25,40.25,39.0,9866,de_market,2,-1.7500019,39.0 - 40.25,1.23,,,41.4,23.7,36.37,35.59,11.33k,17.32k,16.09M,,8.34M,24.94%,34.94%,,,,,,,,,,,0.00%,,,1:4,"Jul 19, 2012","Dec 31, 2020","Dec 31, 2020",0.97%,1.70%,4.29%,5.41%,626.89M,40.57,19.50%,37.12M,12.47M,6.06M,0.38,-0.40%,20.3M,1.26,19.23M,13.51,4.45,8.85,-38.12M,-43.68M,Value,10557,Healthcare,187,"Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures drugs for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.",Berlin,49 30 232 5668 0,1577750400,Germany,http://www.medios.ag,86400,Heidestrasse 9,49 30 232 5668 01,Medical Distribution
t-3,ILM1.DE,51931800.0,16085000,,,2087000,,1584500,3423000,8737000,2138000,2138000,2365000,-151500,,,,502500,146450500,144312500,137713500,-51000,,1584500,1584500,,,81626579.0,,,,,,,,,,,,,,,,,,,,20500,2672500,-1655500,9237000,35028500,-54000,26005000,36832500,3459500,647500,7000,-2402000,-26053000,-213500,1011000,-772000,,en-US,US,EQUITY,False,Delayed Quote,EUR,40.0,39.15,39.3,0,0,finmb_364624951,XETRA,Medios AG,EUR,11330,17319,15.599998,0.65822774,23.7 - 41.4,-2.1000023,-0.050724693,23.7,41.4,1634036340,1634036340,1634036340,103.42105,0.38,0.82,8.855,36.37,2.9300003,0.080560915,35.592255,3.7077446,629432704,47.92683,4.4381704,15,Europe/Berlin,CEST,7200000,False,False,GER,0,REGULAR,0.104172796,MEDIOS AG  O.N.,39.3,1630573220,-0.70000076,40.25,40.25,39.0,9866,de_market,2,-1.7500019,39.0 - 40.25,1.23,,,41.4,23.7,36.37,35.59,11.33k,17.32k,16.09M,,8.34M,24.94%,34.94%,,,,,,,,,,,0.00%,,,1:4,"Jul 19, 2012","Dec 31, 2020","Dec 31, 2020",0.97%,1.70%,4.29%,5.41%,626.89M,40.57,19.50%,37.12M,12.47M,6.06M,0.38,-0.40%,20.3M,1.26,19.23M,13.51,4.45,8.85,-38.12M,-43.68M,Value,10557,Healthcare,187,"Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures drugs for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.",Berlin,49 30 232 5668 0,1577750400,Germany,http://www.medios.ag,86400,Heidestrasse 9,49 30 232 5668 01,Medical Distribution
